The reasons behind design changes do not remain neatly within the code.For example, the decision to 'not separate servers for each client.' Was it for performance, to simplify operations, or due to ...

On September 17, 2026, the FDA approved Ultragenyx's gene therapy Fayuvi (generic name: rebisufligene etisparvovec-hopf). It ...

With a $3.95m price tag, Fayuvi – a one-time gene therapy – is one of the most expensive drugs on the market.

AI data management takes center stage as enterprises push toward agents in production, prompting a major pricing change from ...

Washington is preparing for the right war, but in the wrong theater. For years, U.S. strategic thinking has centered on the ...

Barclays 24th Annual Global Financial Services Conference September 14, 2026 3:30 PM EDTCompany ParticipantsGonzalo Luchetti - ...

Better Business Advice has recognized Needed Prenatal Multivitamin as the leading choice for comprehensive prenatal nutrition in 2026, citing ...

GUYANA’S healthcare sector continues to develop and modernise to meet the medical demands of the nation, with more than $50 billion invested in the first half of 2026, according to the government’s ...

CRN’s Best Of The Channel Awards finalists for Best AI Solution Provider reveal where AI is having the biggest impact on their businesses and solutions.

Spread the loveWhen you trust a financial institution with your money and your most sensitive personal information, there’s an unspoken agreement: they’ll keep it safe. So, when news surfaced that ...

Ethereum sets October 6 for Glamsterdam's Sepolia testnet while warning that fake builders could exploit free test ether to disrupt block auctions.

Fayuvi, Ultragenyx’s gene therapy, wins FDA approval as the first treatment for Sanfilippo syndrome type A. Read the latest details and impact today.